Abstract
Pope et al have concerns about the American Academy of Pediatrics Committee on Infectious Diseases recommendation for using ribavirin in RSV patients who are mechanically ventilated. The Committee based these recommendations not only on the study published by Smith et al, but also on observations on individual patients in clinical situations where experienced care-takers have reported favorable clinical outcomes and safety. Sources included members of the Committee, the Food and Drug Administration, the pharmaceutical manufacturer, a National Institutes of Health panel of scientists, and reviewers and representatives from the National Institute of Occupational Safety and Health.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
